The investigational drug in this research study is being developed for the treatment of spinal muscular atrophy. The purpose of this part of the study is to evaluate the effect food has on the absorption of the study drug, and to collect information on any side effects that may occur when the study drug is taken with food and/or without food. You will receive an oral dose of the study drug.
• Healthy men and women of non-childbearing potential, age 18-55
• BMI (body mass index) 18-32
• Join us for 2 separate stays of 3 overnights, 4 OPVs, and 1 follow-up phone call
• Compensation now up to $4,305 may be provided for time and participation